Search results

See details of previously published customer updates from our Health products team. 

Multi-faceted approach to dating Australian Indigenous rock art from Kimberley region

It's ANSTO's role to keep Australia across the very latest developments in nuclear science and technology from around the world. Part of this responsibility is keeping us abreast of the latest developments in nuclear power technologies.

The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.

Accelerator technique used in pioneering biomaterials research led by the University of Sydney.

ANSTO has agreed to participate in an Australian trial of a review of research infrastructure access proposals in which applicants remain anonymous to aid the removal of structural barriers to the career progression of Women in STEM.

ANSTO Big Ideas encourages students to creatively communicate the work of an Australian scientist, and explain how their work has inspired them to come up with a Big Idea to make our world a better place. This competition is intended to engage and support Australian students in years 7-10 in Science and encourage them to pursue studies and careers in STEM.

X-ray fluorescence scanner is a powerful analytical tool for environmental studies.

In a paper published yesterday, Traditional Owners and researchers report on the oldest securely dated pottery discovered in Australia, located at Jiigurru (Lizard Island Group) on the Great Barrier Reef.

The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.

Monash University is partnering with the Australian Synchrotron and other key institutions to launch a $2.9 million national project – delivering a robotic laboratory capable of drastically speeding up the invention, trials and commercialisation of medicines by Australian researchers.

The protein mapping workhorses of the Australian Synchrotron, Macromolecular and Microfocus crystallography beamlines, MX1 and 2, continue to support important biomedical research in the development of vaccines and new therapeutics.